D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
801
DELISTED
GenMark Diagnostics, Inc
GNMK
| $22.2M | 0.02% |
930,726
-95,494
| -9% | -$1.77M |
|
802
CALL
Oneok
OKE
$58.7B
| $22.2M | 0.02% |
438,800
+286,300
| +188% | +$13M |
|
803
Marriott International
MAR
$98.7B
| $22.1M | 0.02% |
149,392
+117,544
| +369% | +$16M |
|
804
Raymond James Financial
RJF
$32.5B
| $22.1M | 0.02% |
270,729
+43,987
| +19% | +$3.28M |
|
|
GOOS
805
Canada Goose Holdings
GOOS
$868M
| $22M | 0.02% |
561,756
+241,280
| +75% | +$9.54M |
|
806
Carrier Global
CARR
$57.2B
| $22M | 0.02% |
522,183
+516,710
| +9,441% | +$20.1M |
|
|
SPLK
807
CALL
DELISTED
Splunk Inc
SPLK
| $22M | 0.02% |
162,600
-23,400
| -13% | -$3.65M |
|
808
Teladoc Health
TDOC
$1.58B
| $21.8M | 0.02% |
120,002
+91,207
| +317% | +$21.2M |
|
809
Usana Health Sciences
USNA
$394M
| $21.7M | 0.02% |
222,468
+29,318
| +15% | +$2.67M |
|
|
GLDD
810
DELISTED
Great Lakes Dredge & Dock
GLDD
| $21.7M | 0.02% |
1,488,072
+54,236
| +4% | +$791K |
|
811
Prudential Financial
PRU
$41.7B
| $21.6M | 0.02% |
237,155
+227,611
| +2,385% | +$19.5M |
|
812
Ambarella
AMBA
$2.99B
| $21.5M | 0.02% |
214,347
-161,329
| -43% | -$17.6M |
|
813
WaFd
WAFD
$2.72B
| $21.5M | 0.02% |
698,514
+186,050
| +36% | +$5.56M |
|
|
PARA
814
PUT
DELISTED
Paramount Global Class B
PARA
| $21.5M | 0.02% |
477,000
-635,200
| -57% | -$38.8M |
|
815
Sinclair Inc
SBGI
$974M
| $21.5M | 0.02% |
734,584
-22,906
| -3% | -$762K |
|
816
Veeco
VECO
$3.15B
| $21.5M | 0.02% |
1,035,990
-38,036
| -4% | -$791K |
|
|
WBA
817
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $21.4M | 0.02% |
390,700
-228,800
| -37% | -$11.3M |
|
818
Pinnacle West Capital
PNW
$12.9B
| $21.3M | 0.02% |
261,664
-90,859
| -26% | -$7.03M |
|
819
CALL
Capital One
COF
$124B
| $21.3M | 0.02% |
167,300
-39,800
| -19% | -$4.69M |
|
820
FirstService
FSV
$6.32B
| $21.3M | 0.02% |
143,311
-15,000
| -9% | -$2.18M |
|
821
CALL
UnitedHealth
UNH
$382B
| $21.2M | 0.02% |
57,000
-6,600
| -10% | -$2.29M |
|
822
AerCap
AER
$23.9B
| $21.2M | 0.02% |
360,905
-201,289
| -36% | -$9.8M |
|
|
VCRA
823
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $21.2M | 0.02% |
551,185
-206,435
| -27% | -$8.9M |
|
824
IBM
IBM
$202B
| $21.2M | 0.02% |
166,270
+154,808
| +1,351% | +$18.5M |
|
825
Gen Digital
GEN
$15.6B
| $21.2M | 0.02% |
995,214
-727,672
| -42% | -$15.3M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.